![Catholics weigh in as Supreme Court faces deadline on telemedicine abortion ruling #Catholic The U.S. Supreme Court’s stay on the 5th Circuit’s ruling restricting access to telemedicine abortions is set to expire May 11, a deadline that could bring an extension, allow the restrictions to take effect, or prompt the justices to take up the case in full.Michael New, assistant professor of social research at The Catholic University of America’s Busch School of Business, told “EWTN News Nightly” on May 8: “The Supreme Court may extend the stay if they need more time to deliberate; they may simply uphold the 5th Circuit Courtʼs decision that bans tele-abortion, and the ban will go into effect; or they may want to do a full hearing [and] conduct oral arguments.”The Supreme Court on May 4 temporarily blocked a lower court order requiring in‑person dispensing of mifepristone after two manufacturers asked the justices to intervene, prompting Justice Samuel Alito to issue an administrative stay that restores mail‑order access until May 11 at 5 p.m. ET while the court weighs the request.Although Alito instructed the Food and Drug Administration (FDA) and the state of Louisiana to respond by 5 p.m. ET on May 7, the Justice Department failed to do so.New described the development as “odd,” saying the failure by the Justice Department, which represents the FDA, to meet the filing deadline could be that “they don’t want to defend the FDA’s position any longer” or that it may signal a policy change.“Sometimes when people think theyʼre going to lose a case, they change public policy because theyʼd rather change policy than, you know, lose a court case,” New said. “Itʼs really hard to say at this point.”Ultimately, New said the Supreme Court should “absolutely” reinstate in-person requirements to obtain abortion pills, saying: “Thereʼs some real serious public health issues at play here.”Judicial Crisis Network President Carrie Severino gave context for the latest developments in a May 7 interview on EWTN’s “The World Over with Raymond Arroyo,” noting that the FDAʼs ongoing approval of nationwide mail-order abortion effectively circumvents Louisiana law protecting unborn human life. “The court should decide hopefully by the 11th, because thatʼs when the stay expires,” she said. “If they donʼt make any decision, then the 5th Circuit ruling goes back into effect and the FDA will have to disallow mailing of these pills, at least during the pendency of litigation,” said Severino, who is also a former Supreme Court clerk.U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. ordered the FDA to carry out a review of the abortion drug in May 2025, which is still ongoing.Ultimately, Severino said, the Supreme Court will not be ruling on “what the FDA needs to do at the end of the day” but on whether abortion drugs will be allowed to be mailed into Louisiana or not.“Eventually, you know, then itʼs going to go back and the district court and the 5th Circuit are going to have to reconsider it,” she said. “It could well return to the Supreme Court ultimately, but thatʼs going to be a ways down the litigation.”The U.S. Conference of Catholic Bishops (USCCB) has spoken out against the dangers of mail-order abortion drugs for women and urged the FDA to restore in-person visits to screen for life-threatening conditions such as ectopic pregnancies as well as abuse and human trafficking. Catholics weigh in as Supreme Court faces deadline on telemedicine abortion ruling #Catholic The U.S. Supreme Court’s stay on the 5th Circuit’s ruling restricting access to telemedicine abortions is set to expire May 11, a deadline that could bring an extension, allow the restrictions to take effect, or prompt the justices to take up the case in full.Michael New, assistant professor of social research at The Catholic University of America’s Busch School of Business, told “EWTN News Nightly” on May 8: “The Supreme Court may extend the stay if they need more time to deliberate; they may simply uphold the 5th Circuit Courtʼs decision that bans tele-abortion, and the ban will go into effect; or they may want to do a full hearing [and] conduct oral arguments.”The Supreme Court on May 4 temporarily blocked a lower court order requiring in‑person dispensing of mifepristone after two manufacturers asked the justices to intervene, prompting Justice Samuel Alito to issue an administrative stay that restores mail‑order access until May 11 at 5 p.m. ET while the court weighs the request.Although Alito instructed the Food and Drug Administration (FDA) and the state of Louisiana to respond by 5 p.m. ET on May 7, the Justice Department failed to do so.New described the development as “odd,” saying the failure by the Justice Department, which represents the FDA, to meet the filing deadline could be that “they don’t want to defend the FDA’s position any longer” or that it may signal a policy change.“Sometimes when people think theyʼre going to lose a case, they change public policy because theyʼd rather change policy than, you know, lose a court case,” New said. “Itʼs really hard to say at this point.”Ultimately, New said the Supreme Court should “absolutely” reinstate in-person requirements to obtain abortion pills, saying: “Thereʼs some real serious public health issues at play here.”Judicial Crisis Network President Carrie Severino gave context for the latest developments in a May 7 interview on EWTN’s “The World Over with Raymond Arroyo,” noting that the FDAʼs ongoing approval of nationwide mail-order abortion effectively circumvents Louisiana law protecting unborn human life. “The court should decide hopefully by the 11th, because thatʼs when the stay expires,” she said. “If they donʼt make any decision, then the 5th Circuit ruling goes back into effect and the FDA will have to disallow mailing of these pills, at least during the pendency of litigation,” said Severino, who is also a former Supreme Court clerk.U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. ordered the FDA to carry out a review of the abortion drug in May 2025, which is still ongoing.Ultimately, Severino said, the Supreme Court will not be ruling on “what the FDA needs to do at the end of the day” but on whether abortion drugs will be allowed to be mailed into Louisiana or not.“Eventually, you know, then itʼs going to go back and the district court and the 5th Circuit are going to have to reconsider it,” she said. “It could well return to the Supreme Court ultimately, but thatʼs going to be a ways down the litigation.”The U.S. Conference of Catholic Bishops (USCCB) has spoken out against the dangers of mail-order abortion drugs for women and urged the FDA to restore in-person visits to screen for life-threatening conditions such as ectopic pregnancies as well as abuse and human trafficking.](https://unitedyam.com/wp-content/uploads/2026/05/catholics-weigh-in-as-supreme-court-faces-deadline-on-telemedicine-abortion-ruling-catholic-the-u-s-supreme-courts-stay-on-the-5th-circuits-ruling-restricting-access-to-telemedicin-scaled.jpg)
U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. ordered a review of the abortion drug mifipristone in May 2025, which is ongoing.

![Catholics weigh in as Supreme Court faces deadline on telemedicine abortion ruling #Catholic The U.S. Supreme Court’s stay on the 5th Circuit’s ruling restricting access to telemedicine abortions is set to expire May 11, a deadline that could bring an extension, allow the restrictions to take effect, or prompt the justices to take up the case in full.Michael New, assistant professor of social research at The Catholic University of America’s Busch School of Business, told “EWTN News Nightly” on May 8: “The Supreme Court may extend the stay if they need more time to deliberate; they may simply uphold the 5th Circuit Courtʼs decision that bans tele-abortion, and the ban will go into effect; or they may want to do a full hearing [and] conduct oral arguments.”The Supreme Court on May 4 temporarily blocked a lower court order requiring in‑person dispensing of mifepristone after two manufacturers asked the justices to intervene, prompting Justice Samuel Alito to issue an administrative stay that restores mail‑order access until May 11 at 5 p.m. ET while the court weighs the request.Although Alito instructed the Food and Drug Administration (FDA) and the state of Louisiana to respond by 5 p.m. ET on May 7, the Justice Department failed to do so.New described the development as “odd,” saying the failure by the Justice Department, which represents the FDA, to meet the filing deadline could be that “they don’t want to defend the FDA’s position any longer” or that it may signal a policy change.“Sometimes when people think theyʼre going to lose a case, they change public policy because theyʼd rather change policy than, you know, lose a court case,” New said. “Itʼs really hard to say at this point.”Ultimately, New said the Supreme Court should “absolutely” reinstate in-person requirements to obtain abortion pills, saying: “Thereʼs some real serious public health issues at play here.”Judicial Crisis Network President Carrie Severino gave context for the latest developments in a May 7 interview on EWTN’s “The World Over with Raymond Arroyo,” noting that the FDAʼs ongoing approval of nationwide mail-order abortion effectively circumvents Louisiana law protecting unborn human life. “The court should decide hopefully by the 11th, because thatʼs when the stay expires,” she said. “If they donʼt make any decision, then the 5th Circuit ruling goes back into effect and the FDA will have to disallow mailing of these pills, at least during the pendency of litigation,” said Severino, who is also a former Supreme Court clerk.U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. ordered the FDA to carry out a review of the abortion drug in May 2025, which is still ongoing.Ultimately, Severino said, the Supreme Court will not be ruling on “what the FDA needs to do at the end of the day” but on whether abortion drugs will be allowed to be mailed into Louisiana or not.“Eventually, you know, then itʼs going to go back and the district court and the 5th Circuit are going to have to reconsider it,” she said. “It could well return to the Supreme Court ultimately, but thatʼs going to be a ways down the litigation.”The U.S. Conference of Catholic Bishops (USCCB) has spoken out against the dangers of mail-order abortion drugs for women and urged the FDA to restore in-person visits to screen for life-threatening conditions such as ectopic pregnancies as well as abuse and human trafficking. Catholics weigh in as Supreme Court faces deadline on telemedicine abortion ruling #Catholic The U.S. Supreme Court’s stay on the 5th Circuit’s ruling restricting access to telemedicine abortions is set to expire May 11, a deadline that could bring an extension, allow the restrictions to take effect, or prompt the justices to take up the case in full.Michael New, assistant professor of social research at The Catholic University of America’s Busch School of Business, told “EWTN News Nightly” on May 8: “The Supreme Court may extend the stay if they need more time to deliberate; they may simply uphold the 5th Circuit Courtʼs decision that bans tele-abortion, and the ban will go into effect; or they may want to do a full hearing [and] conduct oral arguments.”The Supreme Court on May 4 temporarily blocked a lower court order requiring in‑person dispensing of mifepristone after two manufacturers asked the justices to intervene, prompting Justice Samuel Alito to issue an administrative stay that restores mail‑order access until May 11 at 5 p.m. ET while the court weighs the request.Although Alito instructed the Food and Drug Administration (FDA) and the state of Louisiana to respond by 5 p.m. ET on May 7, the Justice Department failed to do so.New described the development as “odd,” saying the failure by the Justice Department, which represents the FDA, to meet the filing deadline could be that “they don’t want to defend the FDA’s position any longer” or that it may signal a policy change.“Sometimes when people think theyʼre going to lose a case, they change public policy because theyʼd rather change policy than, you know, lose a court case,” New said. “Itʼs really hard to say at this point.”Ultimately, New said the Supreme Court should “absolutely” reinstate in-person requirements to obtain abortion pills, saying: “Thereʼs some real serious public health issues at play here.”Judicial Crisis Network President Carrie Severino gave context for the latest developments in a May 7 interview on EWTN’s “The World Over with Raymond Arroyo,” noting that the FDAʼs ongoing approval of nationwide mail-order abortion effectively circumvents Louisiana law protecting unborn human life. “The court should decide hopefully by the 11th, because thatʼs when the stay expires,” she said. “If they donʼt make any decision, then the 5th Circuit ruling goes back into effect and the FDA will have to disallow mailing of these pills, at least during the pendency of litigation,” said Severino, who is also a former Supreme Court clerk.U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. ordered the FDA to carry out a review of the abortion drug in May 2025, which is still ongoing.Ultimately, Severino said, the Supreme Court will not be ruling on “what the FDA needs to do at the end of the day” but on whether abortion drugs will be allowed to be mailed into Louisiana or not.“Eventually, you know, then itʼs going to go back and the district court and the 5th Circuit are going to have to reconsider it,” she said. “It could well return to the Supreme Court ultimately, but thatʼs going to be a ways down the litigation.”The U.S. Conference of Catholic Bishops (USCCB) has spoken out against the dangers of mail-order abortion drugs for women and urged the FDA to restore in-person visits to screen for life-threatening conditions such as ectopic pregnancies as well as abuse and human trafficking.](https://unitedyam.com/wp-content/uploads/2026/05/catholics-weigh-in-as-supreme-court-faces-deadline-on-telemedicine-abortion-ruling-catholic-the-u-s-supreme-courts-stay-on-the-5th-circuits-ruling-restricting-access-to-telemedicin-scaled.jpg)
U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. ordered a review of the abortion drug mifipristone in May 2025, which is ongoing.

![Maryland Supreme Court: State cannot reveal names of individuals who allegedly hid Church abuse #Catholic Prosecutors in Maryland may not reveal the names of individuals who allegedly hid or failed to report Church abuse, the state Supreme Court said April 27. As part of its investigation into alleged abuse in the Archdiocese of Baltimore, the state attorney generalʼs office had sought to make public the details of a grand jury report, including the identities of individuals who have not been charged with a crime but who allegedly failed to stop abuse from occurring. A lower court granted the attorney generalʼs request to publish the information, with an appellate court partly upholding that decision. Yet in its April 27 ruling, the Maryland Supreme Court reversed those decisions, holding that the attorney generalʼs office did not “meet [the] burden” of justifying the release of the identities. “Many grand jury investigations obtain damaging information and allegations about uncharged individuals that the public might benefit from learning,” the high court acknowledged. But “one of the primary purposes of grand jury secrecy is to protect uncharged persons from public disgrace in the absence of a criminal charge and a forum in which to seek vindication,” it said. “A court may not order disclosure of secret grand jury material, over the objection of an uncharged individual, for the purpose of holding that person accountable in the court of public opinion,” the justices said. The court noted that the attorney generalʼs office had argued that the “intensity of public interest” in the case could justify revealing the identities.Yet “the interests promoted by grand jury secrecy do not increase or decrease based on how much the public wants to learn the information contained in grand jury materials,” the court said.The decision comes amid ongoing court proceedings in the Archdiocese of Baltimore, which filed for bankruptcy in September 2023 ahead of a wave of sex abuse claims filed against it under the Maryland Child Victims Act. Earlier this month, the archdiocesan insurer Hartford Insurance Group proposed contributing $100 million to a settlement for abuse victims. The archdiocese in 2024 sued multiple insurers over what it claimed was a failure to pay abuse claims for which the insurers were contractually obligated.In 2024 Archbishop William Lori attended two court-ordered “listening sessions” with alleged victims of sexual abuse, with the prelate describing himself as "deeply moved by their very powerful testimony.” Maryland Supreme Court: State cannot reveal names of individuals who allegedly hid Church abuse #Catholic Prosecutors in Maryland may not reveal the names of individuals who allegedly hid or failed to report Church abuse, the state Supreme Court said April 27. As part of its investigation into alleged abuse in the Archdiocese of Baltimore, the state attorney generalʼs office had sought to make public the details of a grand jury report, including the identities of individuals who have not been charged with a crime but who allegedly failed to stop abuse from occurring. A lower court granted the attorney generalʼs request to publish the information, with an appellate court partly upholding that decision. Yet in its April 27 ruling, the Maryland Supreme Court reversed those decisions, holding that the attorney generalʼs office did not “meet [the] burden” of justifying the release of the identities. “Many grand jury investigations obtain damaging information and allegations about uncharged individuals that the public might benefit from learning,” the high court acknowledged. But “one of the primary purposes of grand jury secrecy is to protect uncharged persons from public disgrace in the absence of a criminal charge and a forum in which to seek vindication,” it said. “A court may not order disclosure of secret grand jury material, over the objection of an uncharged individual, for the purpose of holding that person accountable in the court of public opinion,” the justices said. The court noted that the attorney generalʼs office had argued that the “intensity of public interest” in the case could justify revealing the identities.Yet “the interests promoted by grand jury secrecy do not increase or decrease based on how much the public wants to learn the information contained in grand jury materials,” the court said.The decision comes amid ongoing court proceedings in the Archdiocese of Baltimore, which filed for bankruptcy in September 2023 ahead of a wave of sex abuse claims filed against it under the Maryland Child Victims Act. Earlier this month, the archdiocesan insurer Hartford Insurance Group proposed contributing $100 million to a settlement for abuse victims. The archdiocese in 2024 sued multiple insurers over what it claimed was a failure to pay abuse claims for which the insurers were contractually obligated.In 2024 Archbishop William Lori attended two court-ordered “listening sessions” with alleged victims of sexual abuse, with the prelate describing himself as "deeply moved by their very powerful testimony.”](https://unitedyam.com/wp-content/uploads/2026/04/maryland-supreme-court-state-cannot-reveal-names-of-individuals-who-allegedly-hid-church-abuse-catholic-prosecutors-in-maryland-may-not-reveal-the-names-of-individuals-who-allegedly-hid-or-failed-to-scaled.jpg)
“Uncharged individuals” may not be exposed to the “court of public opinion” in grand jury documents, the state high court ruled.


The Catholic bishops were among more than 50 intervenors presenting arguments at a landmark Supreme Court of Canada hearing into the constitutionality of Quebec’s 2019 secularism law.
